However, the translational gap between the in vitro efficacy and the in vivo performance of many bioactive compounds (BACs) remains a major bottleneck in the development of efficacious nutraceutical products (1, 2)
I rent a house on the beach somewhere and this time it was in Miami and I just sit, and I spent five days thinking about what my next company would be, he said in an interview
The following search string was used: #1"Parkinson Disease"[mh] OR Parkinson* [tw]) AND #2"Glucagon-Like Peptide 1"[mh] OR"GLP-1 receptor agonists"[tw] OR"glucagon-like peptide-1"[tw] OR GLP-1 [tw] OR liraglutide [tw] OR exenatide [tw] OR dulaglutide [tw] OR semaglutide [tw] OR lixisenatide [tw]) AND #3"Metabolism"[mh] OR metabolism [tw] OR"Body Weight"[mh] OR"body weight"[tw] OR"Obesity"[mh] OR obesity [tw] OR"Diabetes Mellitus"[mh] OR diabetes [tw] OR neuroprotection [tw]) AND English [la] AND ("2000"[dp]:"2025"[dp]) Study Selection The following authors, IAO and CEV, independently reviewed the titles and abstracts of all identified articles
The researchers also couldn't account for some factors, such as socioeconomic status or lifestyle choices, that could affect the results
Commercial insurance (employer-sponsored)